JD HEALTH's stock surged 5.10% during intraday trading on Monday, reflecting strong investor interest in the company's latest strategic initiatives.
The significant price movement follows JD Health's announcement of an upgraded strategic cooperation with Yuwell Medical in the AI medical devices field. The partnership has set an ambitious three-year sales target of RMB 10 billion, aiming to further integrate AI-powered medical devices into JD Health's HomeCare service ecosystem.
Additionally, JD Health has signed a strategic cooperation agreement with Wuhan Wudong Hospital to jointly develop an integrated online-offline mental health service system, expanding access to specialized psychiatric resources. The broader internet healthcare sector also showed strength, providing positive momentum for the stock's performance.
Comments